Oaktree Acquisition Corp. III Life Sciences (Nasdaq: OACC) is a blank check company sponsored by an affiliate of Oaktree Capital Management, one of the largest global alternative investment managers, focused on identifying acquisition targets within the life sciences sector. The company filed its annual report on Form 10-K with the SEC on March 26, 2026, confirming its continued status as an active special purpose acquisition company. OACC is the third SPAC vehicle launched under the Oaktree Acquisition banner, reflecting the sponsor's sustained participation in the SPAC market with a healthcare and life sciences mandate. Sign up at SpacDesk for full filing history, sponsor analytics, and deal-status tracking on OACC and the broader SPAC universe.